Psoriasis drugs market in the United States by therapy class 2016-2022
This statistic shows the psoriasis drugs market in the United States from 2016 to 2022, by therapy class. Psoriasis is a chronic and common disease that is characteristic of red, scaly patches that forms on the skin all over the body. The disease is mediated by the immune system. The largest therapy class within the psoriasis market by 2022 is expected to be interleukin inhibitors, with some 4.4 billion U.S. dollars.
